Lisata Therapeutics (LSTA)

• Market cap: $40.2M
• 1 day: -1.51%
• 5 days: 2.47%
• 1 month: 132.65%
• 3 months: 70.79%
• 6 months: 77.43%
• Year to date: 132.65%
• 1 year: 76.74%
• 5 years: -85.1%
• 10 years: -94.28%
• Sector: Healthcare
• Industry: Biotechnology

About: Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Employees: 26